Health issues concerning exposure to electric and magnetic
fields (EMF) are discussed extensively in the news.
There are a number of products under the regulatory authority
of FDA which emit or utilize EMF radiation. These include electric
blankets, video display terminals, and medical devices such
as those used to treat non-unions (bone fractures), as well
as wireless communications devices such as cellular telephones.
Concern stems, in part, from epidemiological reports suggesting
that EMF may play a role in cancer promotion. The program described
below is part of a national research effort with contributions
from NIH, CDC, DOE, and FDA. The data from this research will
be used in an NIH risk analysis process leading to a Congressional
report. This will place the FDA in a better position to evaluate
safety claims of products emitting EMF. The principal objectives
of the program are (1) to establish and maintain a regional
in vitro magnetic field exposure facility and (2) to perform
studies which address the issue of reproducibility of published
EMF biological effects. This program was supported by NIH, FDA,
and the Office of Naval Research. This program resulted in 10
published abstracts and 3 invited seminars at international
scientific meetings during FY 96.